Credit Acceptance Announces Completion of $500.0 Million Asset-Backed Financing
February 18, 2021 16:02 ET
|
Credit Acceptance Corporation
Southfield, Michigan, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Credit Acceptance Corporation (Nasdaq: CACC) (the “Company”, “Credit Acceptance”, “we”, “our”, or “us”) announced today the completion of a...
Novavax Announces Memorandum of Understanding with Gavi for Cumulative Supply to COVAX Facility of 1.1 Billion Doses of COVID-19 Vaccine
February 18, 2021 16:02 ET
|
Novavax, Inc.
Advances joint commitment from Novavax, Serum Institute of India and Gavi to ensure equitable access to NVX-CoV2373 worldwide across low-, middle- and high-income countriesMemorandum of understanding...
Bio-Path Holdings, Inc. Announces Closing of $13.0 Million Public Offering of Common Stock
February 18, 2021 16:01 ET
|
Bio-Path Holdings, Inc.
HOUSTON, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (Nasdaq:BPTH), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to...
Applied Materials Announces First Quarter 2021 Results
February 18, 2021 16:01 ET
|
Applied Materials, Inc.
Record quarterly revenue of $5.16 billion, up 24 percent year over yearQuarterly GAAP EPS of $1.22 and record non-GAAP EPS of $1.39, up 27 percent and 42 percent year over year, respectivelyGenerated...
Oyster Point Pharma Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business Highlights
February 18, 2021 16:01 ET
|
Oyster Point Pharma, Inc.
OC-01 (Varenicline) Nasal Spray New Drug Application (NDA) Submitted to the U.S. Food and Drug Administration (FDA) for the Treatment of Signs and Symptoms of Dry Eye Disease on December 17, 2020Phase...
Voyager Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results and Participate in Upcoming Investor Conference
February 18, 2021 16:01 ET
|
Voyager Therapeutics, Inc.
CAMBRIDGE, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe...
Texas Roadhouse, Inc. Announces Fourth Quarter 2020 Results and Provides Business Update
February 18, 2021 16:01 ET
|
Texas Roadhouse, Inc
LOUISVILLE, Ky., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Texas Roadhouse, Inc. (NasdaqGS: TXRH), today announced financial results for the 13 and 52 week periods ended December 29, 2020 and provided a...
Paratek Pharmaceuticals to Present at the 10th Annual SVB Leerink Global Healthcare Conference
February 18, 2021 16:01 ET
|
Paratek Pharmaceuticals
BOSTON, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel...
Cara Therapeutics to Announce Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021
February 18, 2021 16:01 ET
|
Cara Therapeutics, Inc.
STAMFORD, Conn., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to...
Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2020 Financial Results After the Close of Markets on Thursday, March 11, 2021
February 18, 2021 16:01 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) today announced that it will release fourth quarter and full year 2020...
- June 10, 2024 15:19 ET DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of VinFast Auto
- June 10, 2024 15:00 ET RAJANT AND EMBOTECH STRATEGIC PARTNERSHIP ADVANCES PORT AUTONOMY